146 related articles for article (PubMed ID: 36229479)
21. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C.
Miyagawa S; Kawasaki S; Makuuchi M
Hepatology; 1996 Aug; 24(2):307-10. PubMed ID: 8690397
[TBL] [Abstract][Full Text] [Related]
22. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary.
Rencz F; Brodszky V; Gulácsi L; Golicki D; Ruzsa G; Pickard AS; Law EH; Péntek M
Value Health; 2020 Sep; 23(9):1235-1245. PubMed ID: 32940242
[TBL] [Abstract][Full Text] [Related]
23. Health-Related Quality of Life and Health Utilities in Metastatic Castrate-Resistant Prostate Cancer: A Survey Capturing Experiences from a Diverse Sample of UK Patients.
Lloyd AJ; Kerr C; Penton J; Knerer G
Value Health; 2015 Dec; 18(8):1152-7. PubMed ID: 26686802
[TBL] [Abstract][Full Text] [Related]
24. Association between locomotive syndrome and the Japanese version of the EQ-5D-5L in middle-aged and elderly people in Japan.
Tanaka S; Ando K; Kobayashi K; Seki T; Hamada T; Machino M; Ota K; Morozumi M; Kanbara S; Ito S; Ishiguro N; Hasegawa Y; Imagama S
Nagoya J Med Sci; 2020 Feb; 82(1):5-14. PubMed ID: 32273627
[TBL] [Abstract][Full Text] [Related]
25. Significance of HB virus infection in an area of Japan with high incidence of liver cirrhosis and hepatocellular carcinoma: an analysis of consecutive studies among inhabitants of Tomié-Town, Goto Islands.
Munehisa T; Nakata K; Fukahori A; Muro T; Kono K; Furukawa R; Kusumoto Y; Iwanaga A; Ishii N; Koji T
Am J Gastroenterol; 1984 Aug; 79(8):633-6. PubMed ID: 6087656
[TBL] [Abstract][Full Text] [Related]
26. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
Moore A; Young CA; Hughes DA
Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
[TBL] [Abstract][Full Text] [Related]
27. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma.
Sasaki Y; Yamada T; Tanaka H; Ohigashi H; Eguchi H; Yano M; Ishikawa O; Imaoka S
Ann Surg; 2006 Nov; 244(5):771-80. PubMed ID: 17060771
[TBL] [Abstract][Full Text] [Related]
28. Health-related quality of life (HRQoL) and health state utilities with chronic hepatitis-B (CHB): A population-based survey in Vietnam.
Tran QV; Vo TQ
J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S80-S86. PubMed ID: 31369538
[TBL] [Abstract][Full Text] [Related]
29. Health-related quality of life in chronic hepatitis B patients.
Ong SC; Mak B; Aung MO; Li SC; Lim SG
Hepatology; 2008 Apr; 47(4):1108-17. PubMed ID: 18318043
[TBL] [Abstract][Full Text] [Related]
30. Comparison of hepatocellular carcinoma with cirrhosis patients undergoing hepatic resection between hepatitis B and C infection.
Shiba H; Ishida Y; Fujiwara Y; Wakiyama S; Gocho T; Ito R; lida T; Suzuki F; Furukawa K; Haruki K; Misawa T; Yanaga K
Hepatogastroenterology; 2013 Oct; 60(127):1746-8. PubMed ID: 24634946
[TBL] [Abstract][Full Text] [Related]
31. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
32. Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV).
Stepanova M; Younossi I; Racila A; Younossi ZM
Value Health; 2018 May; 21(5):612-621. PubMed ID: 29753360
[TBL] [Abstract][Full Text] [Related]
33. Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis.
Wu X; Hong J; Zhou J; Sun Y; Li L; Xie W; Piao H; Xu X; Jiang W; Feng B; Chen Y; Xu M; Cheng J; Meng T; Wang B; Chen S; Kong Y; Ou X; You H; Jia J
Hepatol Int; 2021 Dec; 15(6):1318-1327. PubMed ID: 34843068
[TBL] [Abstract][Full Text] [Related]
34. Estimating EQ-5D utilities based on the Short-Form Long Term Conditions Questionnaire (LTCQ-8).
Tsiachristas A; Potter CM; Rocks S; Peters M; Cundell M; McShane R; Batchelder L; Fox D; Forder JE; Jones K; Waite F; Freeman D; Fitzpatrick R
Health Qual Life Outcomes; 2020 Aug; 18(1):279. PubMed ID: 32795317
[TBL] [Abstract][Full Text] [Related]
35. EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.
Pickard AS; Gooderham M; Hartz S; Nicolay C
J Med Econ; 2017 Jan; 20(1):19-27. PubMed ID: 27471948
[TBL] [Abstract][Full Text] [Related]
36. EQ-5D-5L utilities per health states in Spanish population with knee or hip osteoarthritis.
García-Pérez L; Ramos-García V; Serrano-Aguilar P; Pais-Brito JL; Aciego de Mendoza M; Martín-Fernández J; García-Maroto R; Arenaza JC; Bilbao A
Health Qual Life Outcomes; 2019 Oct; 17(1):164. PubMed ID: 31666071
[TBL] [Abstract][Full Text] [Related]
37. Japanese Population Norms of EQ-5D-5L and Health Utilities Index Mark 3: Disutility Catalog by Disease and Symptom in Community Settings.
Shiroiwa T; Noto S; Fukuda T
Value Health; 2021 Aug; 24(8):1193-1202. PubMed ID: 34372985
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma and chronic persistent hepatitis.
Shikata T; Yamazaki S; Uzawa T
Acta Pathol Jpn; 1977 May; 27(3):297-304. PubMed ID: 200057
[TBL] [Abstract][Full Text] [Related]
39. Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder.
Desroziers K; Aballéa S; Maman K; Nazir J; Odeyemi I; Hakimi Z
Health Qual Life Outcomes; 2013 Nov; 11():200. PubMed ID: 24246044
[TBL] [Abstract][Full Text] [Related]
40. Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
Tramontano AC; Schrag DL; Malin JK; Miller MC; Weeks JC; Swan JS; McMahon PM
Med Decis Making; 2015 Apr; 35(3):371-87. PubMed ID: 25670839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]